National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: Nanodevices
< Back to Main
    Posted: 01/28/2005
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
PDF Version  View/Print PDF
PowerPoint Version  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

President's Cancer Panel Annual Report: 2006-2007

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Slide 21 : Dendrimers previousnext

Research is being done on a number of nanoparticles created to facilitate drug delivery. One such molecule with potential to link treatment with detection and diagnosis is known as a dendrimer. Dendrimers are man-made molecules about the size of an average protein, and have a branching shape. This shape gives them vast amounts of surface area to which scientists can attach therapeutic agents or other biologically active molecules. Researchers aim eventually to create nanodevices that do much more than deliver treatment.

Dendrimers

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov